Suchergebnisse - "Haynes, Andrew S"

PubPharm (6)

1

Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Haynes, A. | Wei, Z. | Anderson, P. | +3

2

Time for a Change : Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2023

von Haynes, A. | Maples, H. | Parker, S.

3

Cefadroxil Comparable to Cephalexin : Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections

enthalten in: Microbiology spectrum | 2022

von Haynes, A. | Prinzi, A. | Silveira, L. | +5

4

Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19

enthalten in: Journal of pediatric hematology/oncology | 2022

von DeVine, M. | Maxwell, S. | Haynes, A. | +2

5

Impact of Antimicrobial Stewardship Bundle on Inpatient Use of Highly Bioavailable Antibacterials

enthalten in: Hospital pediatrics | 2021

von Haynes, A. | MacBrayne, C. | Parker, S.

6

An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients : Revaccination Outcomes Following Pediatric HSCT

enthalten in: Transplantation and cellular therapy | 2021

von Haynes, A. | Curtis, D. | Campbell, K. | +4

CommentIn: Transplant Cell Ther. 2021 Apr;27(4):281-283. - PMID 33836865

1
[1]